United States · FDA National Drug Code directory

gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
70771-1862_ba40713a-2f22-4276-a664-355e7442cda4
Product NDC
70771-1862
Form
TABLET
Composition / generic term
gabapentin
Labeler
Zydus Lifesciences Limited
Marketing category
ANDA
Marketing start / end (source format)
20240125
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 BLISTER PACK in 1 CARTON (70771-1862-4) / 10 TABLET in 1 BLISTER PACK (70771-1862-2) · 70771-1862-4
  • 500 TABLET in 1 BOTTLE (70771-1862-5) · 70771-1862-5
  • 90 TABLET in 1 BOTTLE (70771-1862-9) · 70771-1862-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →